Xu Yang

4.3k total citations
151 papers, 3.0k citations indexed

About

Xu Yang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xu Yang has authored 151 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 32 papers in Oncology and 32 papers in Epidemiology. Recurrent topics in Xu Yang's work include Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Xu Yang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Xu Yang collaborates with scholars based in China, United States and Germany. Xu Yang's co-authors include Haitao Zhao, Xiaobo Yang, Dongxu Wang, Junyu Long, Jianzhen Lin, Yi Bai, Wenjia Sun, Weiwei Huang, Xinting Sang and Anqiang Wang and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xu Yang

136 papers receiving 3.0k citations

Peers

Xu Yang
Zhong Chen China
Jinbo Liu China
Rui M. Gil da Costa Portugal
Caterina Musolino Italy
Yucun Liu China
Wei Wu China
Hiroyuki Suzuki Japan
Hui Liang China
Russell G. Postier United States
Shan Li China
Zhong Chen China
Xu Yang
Citations per year, relative to Xu Yang Xu Yang (= 1×) peers Zhong Chen

Countries citing papers authored by Xu Yang

Since Specialization
Citations

This map shows the geographic impact of Xu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Yang more than expected).

Fields of papers citing papers by Xu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Yang. The network helps show where Xu Yang may publish in the future.

Co-authorship network of co-authors of Xu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Yang. A scholar is included among the top collaborators of Xu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Yang. Xu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiangqi, Shanshan Wang, Nan Zhang, et al.. (2025). Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma. Cancer Immunology Immunotherapy. 74(11). 331–331. 1 indexed citations
2.
3.
4.
Chao, Jiashuo, Hao Wang, Shuofeng Li, et al.. (2024). Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study. Cancer Immunology Immunotherapy. 73(12). 249–249. 3 indexed citations
5.
Yang, Xu, Jing Wang, Zhanhong Liu, et al.. (2024). Cartilage regeneration achieved in photo-crosslinked hyaluronic hydrogel bioactivated by recombinant humanized collagen type III. Composites Part B Engineering. 288. 111886–111886. 6 indexed citations
6.
Hou, Xintong, Chunyan Zhang, Xu Yang, et al.. (2024). Rogersonins C–F, 9H-Imidazo[2,1-i]purine-Incorporating Adenine-Polyketide Hybrids from an Ophiocordyceps-Associated Clonostachys rogersoniana. Journal of Natural Products. 87(6). 1618–1627. 2 indexed citations
7.
Tong, Junjie, Yang Zhang, Xu Yang, et al.. (2023). Spirocitrinols A and B, citrinin derivatives with a spiro[chromane-2,3′-isochromane] skeleton from Penicillium citrinum. RSC Advances. 13(9). 6124–6129. 4 indexed citations
8.
Han, Tao, Lei Yan, Ming‐Hui Sun, et al.. (2023). Robustness of hypofractionated breast radiotherapy after breast-conserving surgery with free breathing. Frontiers in Oncology. 13. 1259851–1259851. 1 indexed citations
9.
Zhang, Yang, Yiqing Zhang, Xu Yang, et al.. (2022). Cladoxanthones A and B, Xanthone-Derived Metabolites with a Spiro[cyclopentane-1,2′-[3,9a]ethanoxanthene]-2,4′,9′,11′-tetraone Skeleton from a Cladosporium sp.. Journal of Natural Products. 85(11). 2541–2546. 7 indexed citations
10.
Yang, Xu, et al.. (2021). Cardiac paraganglioma with sulfur subunit B gene mutation: a case report. European Heart Journal - Case Reports. 5(2). ytab025–ytab025. 2 indexed citations
11.
Hou, Xintong, Xu Yang, Yang Zhang, et al.. (2020). Sarcosenones A–C, highly oxygenated pimarane diterpenoids from an endolichenic fungus Sarcosomataceae sp.. RSC Advances. 10(26). 15622–15628. 2 indexed citations
12.
Bian, Jin‐Song, Xu Yang, Huimin Zhang, et al.. (2020). Clinical utility value of urinary aldosterone detection by tandem mass spectrometry in primary hyperaldosteronism screening. Zhonghua jianyan yixue zazhi. 43(3). 261–266. 2 indexed citations
13.
Wang, Yu, Xu Yang, Lei Wang, et al.. (2020). Quality appraisal of clinical guidelines for venous thromboembolism prophylaxis in patients undergoing hip and knee arthroplasty: a systematic review. BMJ Open. 10(12). e040686–e040686. 5 indexed citations
14.
Lin, Jianzhen, Junping Shi, Honglin Guo, et al.. (2019). Alterations in DNA Damage Repair Genes in Primary Liver Cancer. Clinical Cancer Research. 25(15). 4701–4711. 80 indexed citations
15.
Long, Junyu, Peipei Chen, Jianzhen Lin, et al.. (2019). DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Theranostics. 9(24). 7251–7267. 99 indexed citations
16.
Luo, Jia, Xiaojing Wang, Fuyin Ma, et al.. (2018). Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study. Clinical Microbiology and Infection. 25(11). 1422–1427. 10 indexed citations
17.
Yang, Xu, Nan Zhao, Lanping Zhou, et al.. (2014). Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells. PLoS ONE. 9(6). e100127–e100127. 37 indexed citations
18.
Liu, Cheng-Yi, et al.. (2013). Roles of autophagy-related genes Beclin-1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia. Biomedical Reports. 1(6). 855–860. 43 indexed citations
19.
Yang, Xu, Lanping Zhou, Jing Huang, et al.. (2011). Role of Smac in Determining the Chemotherapeutic Response of Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 17(16). 5412–5422. 31 indexed citations
20.
Yang, Xu. (2004). Close relation of hepatocellular carcinoma to HBV infection in North China. Zhonghua gan-dan waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhong Chen Breakdown of academic impact, for papers by Jinbo Liu Breakdown of academic impact, for papers by Rui M. Gil da Costa Breakdown of academic impact, for papers by Caterina Musolino Breakdown of academic impact, for papers by Yucun Liu Breakdown of academic impact, for papers by Wei Wu Breakdown of academic impact, for papers by Hiroyuki Suzuki Breakdown of academic impact, for papers by Hui Liang Breakdown of academic impact, for papers by Russell G. Postier Breakdown of academic impact, for papers by Shan Li
Rankless by CCL
2026